Brain Sciences | Highly Cited Papers from 2023 in the “Neuropsychiatry” Section
The “Neuropsychiatry” Section gathers the best available scientific evidence to guide clinical practice in the treatment of psychiatric illnesses. Submissions of original articles and reviews which advance our understanding of the etiology, course, and treatment of psychiatric illnesses are invited. Papers reporting sound evidence-based practices which provide safeguards against reporting bias and promote the reproducibility of study procedures and the replicability of results, for example through the preregistration of study hypotheses, are especially welcome.
As all of the articles published in our journal are of an open access format, you have free and unlimited access to the full texts. We invited you to read our most highly cited papers published in 2023, which are listed below.
1. “Endocannabinoid System and Exogenous Cannabinoids in Depression and Anxiety: A Review”
by Ahmed Hasbi, Bertha K. Madras and Susan R. George
Brain Sci. 2023, 13(2), 325; https://doi.org/10.3390/brainsci13020325
Available online: https://www.mdpi.com/2076-3425/13/2/325
2. “The Role of Brain-Derived Neurotrophic Factor (BDNF) in Diagnosis and Treatment of Epilepsy, Depression, Schizophrenia, Anorexia Nervosa and Alzheimer’s Disease as Highly Drug-Resistant Diseases: A Narrative Review”
by Aleksandra Gliwińska, Justyna Czubilińska-Łada, Gniewko Więckiewicz, Elżbieta Świętochowska, Andrzej Badeński, Marta Dworak and Maria Szczepańska
Brain Sci. 2023, 13(2), 163; https://doi.org/10.3390/brainsci13020163
Available online: https://www.mdpi.com/2076-3425/13/2/163
3. “Application of Antipsychotic Drugs in Mood Disorders”
by Janusz K. Rybakowski
Brain Sci. 2023, 13(3), 414; https://doi.org/10.3390/brainsci13030414
Available online: https://www.mdpi.com/2076-3425/13/3/414
4. “Measuring Social Camouflaging in Individuals with High Functioning Autism: A Literature Review”
by Ivan Mirko Cremone, Barbara Carpita, Benedetta Nardi, Danila Casagrande, Rossella Stagnari, Giulia Amatori and Liliana Dell’Osso
Brain Sci. 2023, 13(3), 469; https://doi.org/10.3390/brainsci13030469
Available online: https://www.mdpi.com/2076-3425/13/3/469
5. “Is It Time for a Paradigm Shift in the Treatment of Schizophrenia? The Use of Inflammation-Reducing and Neuroprotective Drugs—A Review”
by Antonino Messina, Carmen Concerto, Alessandro Rodolico, Antonino Petralia, Filippo Caraci and Maria Salvina Signorelli
Brain Sci. 2023, 13(6), 957; https://doi.org/10.3390/brainsci13060957
Available online: https://www.mdpi.com/2076-3425/13/6/957
6. “Depression in Major Neurodegenerative Diseases and Strokes: A Critical Review of Similarities and Differences among Neurological Disorders”
by Javier Pagonabarraga, Cecilio Álamo, Mar Castellanos, Samuel Díaz and Sagrario Manzano
Brain Sci. 2023, 13(2), 318; https://doi.org/10.3390/brainsci13020318
Available online: https://www.mdpi.com/2076-3425/13/2/318
7. “Brexpiprazole—Pharmacologic Properties and Use in Schizophrenia and Mood Disorders”
by Marcin Siwek, Krzysztof Wojtasik-Bakalarz, Anna Julia Krupa and Adrian Andrzej Chrobak
Brain Sci. 2023, 13(3), 397; https://doi.org/10.3390/brainsci13030397
Available online: https://www.mdpi.com/2076-3425/13/3/397
8. “Long-Term Lithium Therapy and Thyroid Disorders in Bipolar Disorder: A Historical Cohort Study”
by Boney Joseph, Nicolas A. Nunez, Vanessa Pazdernik, Rakesh Kumar, Mehak Pahwa, Mete Ercis, Aysegul Ozerdem, Alfredo B. Cuellar-Barboza, Francisco Romo-Nava, Susan L. McElroy et al.
Brain Sci. 2023, 13(1), 133; https://doi.org/10.3390/brainsci13010133
Available online: https://www.mdpi.com/2076-3425/13/1/133
9. “Epigenetic Targets in Schizophrenia Development and Therapy”
by Agnieszka Wawrzczak-Bargieła, Wiktor Bilecki and Marzena Maćkowiak
Brain Sci. 2023, 13(3), 426; https://doi.org/10.3390/brainsci13030426
Available online: https://www.mdpi.com/2076-3425/13/3/426
10. “Oxidative Stress Biomarkers among Schizophrenia Inpatients”
by Magdalena Więdłocha, Natalia Zborowska, Piotr Marcinowicz, Weronika Dębowska, Marta Dębowska, Anna Zalewska, Mateusz Maciejczyk, Napoleon Waszkiewicz and Agata Szulc
Brain Sci. 2023, 13(3), 490; https://doi.org/10.3390/brainsci13030490
Available online: https://www.mdpi.com/2076-3425/13/3/490
11. “Research and Diagnostic Algorithmic Rules (RADAR) and RADAR Plots for the First Episode of Major Depressive Disorder: Effects of Childhood and Recent Adverse Experiences on Suicidal Behaviors, Neurocognition and Phenome Features”
by Michael Maes and Abbas F. Almulla
Brain Sci. 2023, 13(5), 714; https://doi.org/10.3390/brainsci13050714
Available online: https://www.mdpi.com/2076-3425/13/5/714
12. “Comorbidity and Overlaps between Autism Spectrum and Borderline Personality Disorder: State of the Art”
by Liliana Dell’Osso, Ivan Mirko Cremone, Benedetta Nardi, Valeria Tognini, Lucrezia Castellani, Paola Perrone, Giulia Amatori and Barbara Carpita
Brain Sci. 2023, 13(6), 862; https://doi.org/10.3390/brainsci13060862
Available online: https://www.mdpi.com/2076-3425/13/6/862
13. “Regulatory Clearance and Approval of Therapeutic Protocols of Transcranial Magnetic Stimulation for Psychiatric Disorders”
by Gonçalo Cotovio, Fabiana Ventura, Daniel Rodrigues da Silva, Patrícia Pereira and Albino J. Oliveira-Maia
Brain Sci. 2023, 13(7), 1029; https://doi.org/10.3390/brainsci13071029
Available online: https://www.mdpi.com/2076-3425/13/7/1029
14. “Rumination as a Transdiagnostic Phenomenon in the 21st Century: The Flow Model of Rumination”
by Stephanie M. Y. Wong, Eric Y. H. Chen, Michelle C. Y. Lee, Y. N. Suen and Christy L. M. Hui
Brain Sci. 2023, 13(7), 1041; https://doi.org/10.3390/brainsci13071041
Available online: https://www.mdpi.com/2076-3425/13/7/1041
15. “Lethal Lust: Suicidal Behavior and Chemsex—A Narrative Review of the Literature”
by Martina Strasser, Theresa Halms, Tobias Rüther, Alkomiet Hasan and Marcus Gertzen
Brain Sci. 2023, 13(2), 174; https://doi.org/10.3390/brainsci13020174
Available online: https://www.mdpi.com/2076-3425/13/2/174
16. “Breathwork Interventions for Adults with Clinically Diagnosed Anxiety Disorders: A Scoping Review”
by Blerida Banushi, Madeline Brendle, Anya Ragnhildstveit, Tara Murphy, Claire Moore, Johannes Egberts and Reid Robison
Brain Sci. 2023, 13(2), 256; https://doi.org/10.3390/brainsci13020256
Available online: https://www.mdpi.com/2076-3425/13/2/256
17. “Depression Is Associated with an Increased Risk of Subsequent Cancer Diagnosis: A Retrospective Cohort Study with 235,404 Patients”
by Hannah Mössinger and Karel Kostev
Brain Sci. 2023, 13(2), 302; https://doi.org/10.3390/brainsci13020302
Available online: https://www.mdpi.com/2076-3425/13/2/302
18. “Novel Compounds in the Treatment of Schizophrenia—A Selective Review”
by Evangelia Maria Tsapakis, Kalliopi Diakaki, Apostolos Miliaras and Konstantinos N. Fountoulakis
Brain Sci. 2023, 13(8), 1193; https://doi.org/10.3390/brainsci13081193
Available online: https://www.mdpi.com/2076-3425/13/8/1193
19. “Abnormalities of EEG Functional Connectivity and Effective Connectivity in Children with Autism Spectrum Disorder”
by Xinling Geng, Xiwang Fan, Yiwen Zhong, Manuel F. Casanova, Estate M. Sokhadze, Xiaoli Li and Jiannan Kang
Brain Sci. 2023, 13(1), 130; https://doi.org/10.3390/brainsci13010130
Available online: https://www.mdpi.com/2076-3425/13/1/130
20. “The Comorbidity of Depression and Anxiety Symptoms in Tinnitus Sufferers: A Network Analysis”
by Xuemin Chen, Lei Ren, Xinmiao Xue, Ning Yu, Peng Liu, Weidong Shen, Hanwen Zhou, Ben Wang, Jingcheng Zhou, Shiming Yang et al.
Brain Sci. 2023, 13(4), 583; https://doi.org/10.3390/brainsci13040583
Available online: https://www.mdpi.com/2076-3425/13/4/583
21. “The Role of Ketamine in the Treatment of Bipolar Depression: A Scoping Review”
by Muhammad Youshay Jawad, Saleha Qasim, Menglu Ni, Ziji Guo, Joshua D. Di Vincenzo, Giacomo d’Andrea, Aniqa Tabassum, Andrea Mckenzie, Sebastian Badulescu, Iria Grande et al.
Brain Sci. 2023, 13(6), 909; https://doi.org/10.3390/brainsci13060909
Available online: https://www.mdpi.com/2076-3425/13/6/909